门冬胰岛素30治疗2型糖尿病临床观察  

The clincal effect of insulin aspart 30 on type 2 diabetes

作　　者：方懿珊[1] 林昱[1] 林小燕[1] 魏奕娜[1] 

机构地区：[1]揭阳市人民医院,广东揭阳522000

出　　处：《现代保健（医学创新研究）》2008年第9期30-31,共2页

摘　　要：目的观察30例2型糖尿病患者应用门冬胰岛素30治疗的前瞻性研究。方法在饮食控制合理运动的基础上，停用原口服降糖药，改为门冬胰岛素30进行治疗。结果门冬胰岛素30治疗4周后空腹血糖（FPG）、餐后2h血糖（2h PG）均明显下降（P〈0．01和P〈0．05）。低血糖发生率低。结论门冬胰岛素30能很好模拟人胰岛素分泌模式，实现更优降糖，且低血糖发生率低。Objective A forward - looking research by observing 30 cases of type 2 diabetics who take the biphasic insulin aspart 30, Method On the control diet and rationalization exercise preclinically, stop hypoglycemic before to uesed and treatment by insulin aspart 30. Result After 4 weeks, both the FPG and the 2h PG decrease evidently（ drop to P 〈 0. 01 and P 〈 0.05 ）. The rate of hypoglycemia is lower than before. Conclusion The biphasic insulin aspart 30 can simulate the way of human insulin excreting. It has the better effection in making the level of blood sugar decrease. The rate of hypoglycemia is lower than the cases before as well.

关 键 词：门冬胰岛素30 2型糖尿病 低血糖 

分 类 号：R587.1[医药卫生—内分泌]